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Omics Assisted N-terminal Proteoform and
Protein Expression Profiling On Methionine
Aminopeptidase 1 (MetAP1) Deletion*□S
Veronique Jonckheere‡§¶, Daria Fijałkowska‡§, and Petra Van Damme‡§¶
Excision of the N-terminal initiator methionine (iMet) res-
idue from nascent peptide chains is an essential and om-
nipresent protein modification carried out by methionine
aminopeptidases (MetAPs) that accounts for a major
source of N-terminal proteoform diversity. Although
MetAP2 is known to be implicated in processes such as
angiogenesis and proliferation in mammals, the physio-
logical role of MetAP1 is much less clear. In this report we
studied the omics-wide effects of human MetAP1 deletion
and general MetAP inhibition. The levels of iMet retention
are inversely correlated with cellular proliferation rates.
Further, despite the increased MetAP2 expression on
MetAP1 deletion, MetAP2 was unable to restore process-
ing of Met-Ser-, Met-Pro-, and Met-Ala- starting N termini
as inferred from the iMet retention profiles observed,
indicating a higher activity of MetAP1 over these N ter-
mini. Proteome and transcriptome expression profiling
point to differential expression of proteins implicated in
lipid metabolism, cytoskeleton organization, cell prolif-
eration and protein synthesis upon perturbation of
MetAP activity. Molecular & Cellular Proteomics 17:
10.1074/mcp.RA117.000360, 694–708, 2018.
Protein biogenesis is one of the most fundamental and
complex biological processes, with important implications for
human health and disease. The concerted action of the ribo-
some and numerous ribosome-associated factors is essential
to ensure proper initiation of translation, protein folding, proc-
essing and targeting. By the successive steps of ternary com-
plex recruitment, ribosome scanning, start codon selection
and ribosomal subunit joining, translation initiation acts as the
gate-keeping step of translation. Here, protein biogenesis
initiates with either an initiator N-formylmethionine (fMet)1 in
case of bacterial and eukaryotic organellar protein synthesis,
or an initiator methionine (iMet) in case of archaeal and eu-
karyotic cytosolic protein synthesis.
Typically, for more than half of all nascent protein chains,
the iMet is cotranslationally removed by the action of methi-
onine aminopeptidases (MetAPs), a process referred to as
N-terminal (Nt-) methionine excision (NME) (1). MetAPs rep-
resent a family of conserved and essential enzymes, as in-
ferred from the lethality of the map null mutant in case of
Salmonella typhimurium and Escherichia coli (2). Although
typically only one MetAP gene is found in the genome of
prokaryotes, eukaryotes express at least two types of cyto-
solic MetAPs belonging to a family of evolutionary conserved
metalloproteases, being a type 1 and type 2 MetAP.
Although MetAP2 by itself was shown to be essential for the
development of specific tissues in multicellular organisms (3),
and MetAP1 appears to be vital for cell proliferation, a clear
redundancy between MetAP1 and MetAP2 has been ob-
served in Arabidopsis thaliana and Saccharomyces cerevisiae.
Not surprisingly, double deletion mutants are nonviable, again
pointing to their essential nature (4, 5). Further, and irrespec-
tive of their limited sequence identity, the catalytic domains of
both MetAPs adopt a similar protein fold encompassing a
highly conserved pocket for iMet binding (6, 7).
In case of eubacterial, mitochondrial and plastid NME,
MetAPs remove the iMet of nascent polypeptide chains only
after deformylation by the action of peptide deformylases
(PDF) (8, 9). Further, the manifestation of (the extent of) iMet
processing by MetAPs typically relates to the identity of the
extreme N-terminal residues of the nascent polypeptide
chain. More specifically, MetAPs only cleave iMet from nas-
cent polypeptide chains in case of penultimate N-terminal
residues (P1) with (relatively) small and uncharged side
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chains (i.e. Gly, Ser, Ala, Pro, Cys, Thr, or Val) (10). The latter
referred to as NME compatible residues. Furthermore, amino
acid residues beyond P1may also contribute to the efficiency
of NME (11–15). Interestingly and although still unclear, the
need for having a MetAP of eubacterial and archaeal origin,
being MetAP1 and MetAP2 respectively, might be attributed
to (slight) differences in their substrate specificity profiles.
Further, the N-terminal amino acid sequence is also the
major feature determining whether or not a given protein is
Nt-acetylated and by which Nt-acetyltransferase or NAT (16).
As such, the interplay among other co-translational acting
modifiers, such as the NATs responsible for the cotransla-
tional Nt-acetylation of a large cohort of proteins in case of
eukaryotes (17–19), has also been implicated in determining
MetAP susceptibility and thus (the extend of) iMet retention.
More specifically we have previously shown Nt-acetylated
iMet to be refractory toward the action of MetAPs (20).
By having different processing enzymes operating at the
ribosomal exit tunnel, each nascent protein may under-
go several cotranslational modifications before being fully
matured.
Consequently, different N-terminal proteoforms might dis-
play characteristic functionalities, such as altered protein sta-
bilities (21–23) and subcellular localization. Consequently, Nt-
modifications contribute to the increase of protein complexity
observed.
In this study, we studied the omics-wide effects of human
MetAP1 deletion using a human haploid HAP1 MetAP1
knockout cell line model and compared it to general MetAP
inhibition using Bengamide B, a marine-derived natural prod-
uct with broad spectrum antitumor activity which functions as
a nanomolar inhibitor of MetAPs 1 and 2 (24). The use of these
different setups additionally enable discriminating more direct
from indirect MetAP actions. By enriching for protein N termini
using positional proteomics, we revealed the in vivo substrate
profile of MetAP1 at the proteome-wide level, thereby aiding
in elucidating the functional role of MetAPs. Furthermore, our
proteome analysis showed that the increased expression of
MetAP2 observed on MetAP1 deletion was unable to restore
processing of MS-, MP- and MA- N termini, overall pointing to
MetAP1 as the MetAP being exclusively or more active over
these N termini and providing increasing knowledge on the in
vivo substrate repertoire of MetAPs.
Only in specific cases of which the iMet-processed and
iMet unprocessed Nt-proteoforms could be observed, iMet
processing affected the steady-state Nt-acetylation levels of
Nt-proteoforms. Interestingly, changes in steady-state protein
expression levels were typically explained at the transcript
level and not related to protein N-terminal amino acid identi-
ties. More specifically, upon perturbation of MetAP activity,
omics expression profiling revealed differential expression of
proteins implicated in lipid metabolism, cytoskeleton organi-
zation, cell proliferation and protein synthesis.
EXPERIMENTAL PROCEDURES
Cell Culture—HAP1 control cells (HAP1 WT) and CRISPR/Cas9
edited human METAP1 knockout cells (HAP1 MetAP1 KO) containing
a frameshift mutation in a coding exon of METAP1 (i.e. HAP1 cells
carrying a 179bp insertion ‘ATACAGAGTGACATAATGGACACTANA-
GACTCANAGTGGGGAGGGTAAGAGGGGGGCAAGGNATAAAAAA-
CCACATATTGGGTACAATGTACACTACTCAGGTGACCGGTGCAG-
TAAAATCTCANACTTCNCTACTGTAGAATTCATCTATATGACCAAA-
AGCCATTTGTACCCCAAAA’ in exon 4 of NM_015143 at chr4:
99035439, leading to the corresponding MetAP1 genomic sequence
of CAAAGACCAGAT(179 bp insertion)TATGCTGATCAT which was
sequence verified by Sanger sequencing on PCR amplification from
purified genomic DNA using the following primers; CTTTCTAAATAC-
CCTGCAAAAGGGG (forward) and TCTTCAATGTTCTAATGGTG-
CTTG (reverse)) were obtained from Horizon Genomics GmbH (Vi-
enna, Austria) and cultured in Iscove’s Modified Dulbecco’s Medium
(IMDM) supplemented with 10% fetal bovine serum (Invitrogen, Carls-
bad, CA), 50 units/ml penicillin and 50 g/ml streptomycin (Invitro-
gen). Cells were cultured at 37 °C in a humidified atmosphere with 5%
CO2 and passaged every 3–4 days. For the MetAP1/2 inhibition
experiments, 0.1 M f.c. Bengamide B (sc-397521A, Santa Cruz
Biotechnology, Dallas, TX) was added to HAP1 cells cultured at about
80% of confluency. For proteome-analyses, cells were harvested
after 24 h of treatment.
Immunoblot Analysis—Cold PBS washed HAP1 cells were lysed for
5 min on ice in RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1%
Nonidet P-40) with protease inhibitors added (Roche, Basel, Switzer-
land). For MetAP1 detection, HAP1 cells were lysed in urea lysis
buffer (9 M urea, 50 mm NH4HCO3 (pH 7.9)) by three rounds of
freeze-thaw lysis in liquid in N2. The urea lysates were sonicated
(Branson probe sonifier output 4, 50% duty cycle, 3  30 s, 1 s
pulses) followed by centrifugation for 10 min at 16,100  g (4 °C). All
lysates were cleared by centrifugation for 10 min at 16,100 g and
protein concentration of the measured using the DC Protein Assay Kit
(Bio-Rad, Munich, Germany). Sample loading buffer was added and
equal amounts of protein (between 40 g and 100 g/sample) were
separated by SDS-PAGE (1.0 mm thick 12% polyacrylamide Criterion
Bis-Tris XT- gels, Bio-Rad) in MOPS buffer (Bio-Rad) at 150 V. Sub-
sequently, proteins were transferred onto a PVDF membrane. Mem-
branes were blocked for 30 min in a 1:1 Tris-buffered saline and 0.1%
Tween-20 (TBS-T) Odyssey Blocking solution (cat n° 927–40003,
LI-COR, Lincoln, NE) and probed by Western blotting. Following
overnight incubation of primary antibody in TBS-T/Odyssey blocking
buffer and three 10 min washes in TBS-T, membranes were incubated
with secondary antibody for 1 h in TBS-T/Odyssey blocking buffer
followed by 3 washes in TBS-T or TBS (last wash step). The following
antibodies were used: rabbit anti-actin (A2066, Sigma, Saint-Louis,
MO), mouse monoclonal unprocessed 14-3-3 (iMet 14-3-3)
(NB100–407, Novus Biologicals, Littleton, CO), rabbit polyclonal
14-3-3 (orb128923, Biorbyt, Cambridge, UK), rabbit polyclonal anti-
MetAP1 (NBP1–53088, Novus Biologicals), rabbit polyclonal anti-
MetAP2 (orb33856, Biorbyt), rabbit anti-COTL (orb39513, Biorbyt),
mouse monoclonal anti-cytokeratin 18 (ab668, Abcam, Cambridge,
UK), rabbit anti-CRABP2 (orb32974, Biorbyt), rabbit anti-RL26A
(ab59652, Abcam), rabbit anti-DUSP9 (orb338892, Biorbyt), rabbit
anti-HMGCS (orb36825, Biorbyt), anti-mouse (IRDye 800 CW goat
anti-mouse antibody IgG, LI-COR, cat n° 926–32210) and anti-rabbit
(IRDye 800CW goat anti-rabbit IgG, LI-COR, cat n° 926–32211). The
bands were visualized using an Odyssey infrared imaging system
(LI-COR) and the intensity of bands assessed using the LICOR Od-
yssey software for Western blot image processing.
Proteome Sample Preparation for Shotgun Analyses—Cell pellets
of WT (HAP1 WT) and METAP1 KO (HAP1 MetAP1 KO) cells obtained
from 3 independent cell cultures and containing approx. 10  106
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cells per pellet, were collected and stored at 80 °C until further
processing. HAP1 cell pellets resuspended in 400 l Gu.HCl lysis
buffer (4 M GdmCl, 50 mm NH4HCO3 (pH 7.9)) were lysed by three
rounds of freeze-thaw lysis in liquid in N2. The lysates were sonicated
(Branson probe sonifier output 4, 50% duty cycle, 3  30 s, 1 s
pulses) followed by centrifugation for 10 min at 16,100  g (4 °C), the
supernatant removed and protein concentration determined by Brad-
ford measurement according to the manufacturer’s instructions. An
aliquot equivalent of 200 g (5  106 cells) was transferred to a
clean tube, diluted to 1 mg/ml with lysis buffer, 2 diluted with HPLC
grade water, and precipitated with 4 volumes of 20 °C acetone
overnight. The precipitated protein material was recovered by centri-
fugation for 15 min at 3500  g (4 °C), pellets washed twice with
20 °C 80% acetone, and air dried upside down for10 min at RT or
until no residual acetone odor remained. Pellets were resuspended in
200 l TFE (2,2,2-trifluoroethanol) digestion buffer (10% TFE, 100 mM
ammonium bicarbonate) with sonication until a homogenous suspen-
sion was reached. All samples were digested overnight at 37 °C using
mass spec grade trypsin/Lys-C Mix (Promega, Madison, WI) (enzyme/
substrate of 1:50 w/w) while mixing (550 rpm). Samples were acidified
with TFA to a final concentration of 0.5%. Samples were cleared from
insoluble particulates by centrifugation for 10 min at 16,100 g (4 °C)
and the supernatant transferred to clean tubes. Methionine oxidation
was performed by the addition of H2O2 to reach a f.c. of 0.5% for 30
at 30 °C. Solid phase extraction of peptides was performed using C18
reversed phase sorbent containing 100 l pipette tips (Bond Elut
OMIX 100 l C18 tips (Agilent, Santa Clara, CA) according to the
manufacturer’s instructions. The pipette tip was conditioned by aspi-
rating the maximum pipette tip volume of water:acetonitrile, 50:50
(v/v) and the solvent discarded. After equilibration of the tip by wash-
ing 3 times with the maximum pipette tip volume in 0.1% TFA in
water, 100 l of the acidified samples (200 g) were dispensed and
aspirated for 10 cycles for maximum binding efficiency. The tip was
washed 3 times with the maximum pipette tip volume of 0.1% TFA in
water:acetonitrile, 98:2 (v/v) and the bound peptides eluted in LC-
MS/MS vials with the maximum pipette tip volume of 0.1% TFA in
water:acetonitrile, 30:70 (v/v). The samples were vacuum-dried in a
SpeedVac concentrator and re-dissolved in 20 l of 2 mM tris(2-
carboxyethyl)phosphine in 2% acetonitrile.
Proteome Sample Preparation for N-terminal Peptide Enrichment
Analyses—Pellets of WT (HAP1 WT) and METAP1 KO (HAP1 MetAP1
KO) cells obtained from 3 independent cell cultures (i.e. correspond-
ing cultures of the shotgun proteome analysis) and containing approx.
50  106 cells per pellet, were collected and stored at 80 °C until
further processing. HAP1 cell pellets resuspended in 50 mm
NH4HCO3 (pH 7.9) with protease inhibitors added (Roche) were lysed
by three rounds of freeze-thaw lysis in liquid N2 and the lysates
cleared by centrifugation for 10 min at 16,000  g. Solid guanidinum
hydrochloride was added to the supernatant to a final concentration
of 4 M and the protein samples (equivalent of 2 mg) were reduced and
S-alkylated. All primary protein amines were blocked using an N-
hydroxysuccinimide ester of (stable isotopic encoded) acetate at the
protein level (i.e. an NHS ester of 13C2D3 acetate) to enable the
assignment and the calculation of the degree of in vivo Nt-acetylation
events (25). All modified proteome samples were digested overnight
at 37 °C using mass spec grade trypsin/Lys-C Mix (enzyme/substrate
of 1:50 w/w) while mixing (550 rpm) and the resulting peptide mixtures
vacuum dried. N-terminal peptide enrichment by SCX was performed
as described previously (26). The eluted fraction enriched for Nt-
peptides were vacuum dried and re-dissolved in 1 ml of 0.5% TFA in
2% acetonitrile. Samples were cleared from insoluble particulates by
centrifugation for 10 at 16,100 g and 4 °C, and the supernatant
transferred to clean tubes. Methionine oxidation was performed on
100 l of acidified sample (200 g) by the addition of H2O2 to reach
a f.c. of 0.5% for 30 at 30 °C. Solid phase extraction of peptides was
performed using C18 reversed phase sorbent containing 100 l pi-
pette tips as described above.
RNA Isolation, RNA Sequencing Library Preparation, Sequencing
and mRNA-seq Data Processing—RNA was isolated from HAP1 cells
using the TRIzol reagent (Invitrogen) according to manufacturer’s
instructions. RNA yields were determined using a NanoDrop spectro-
photometer (Wilmington, Delaware) and RNA quality was assessed by
Agilent Bioanalyzer RNA 6000 Nano Kit. Only samples with RIN values
above 9 were accepted. Library generation including random frag-
mentation, cDNA synthesis and sequencing was performed at the VIB
Nucleomics Core (www.nucleomics.be) using the TruSeq stranded
total RNA sample preparation kit (Illumina, San Diego, CA) and in-
cluding a Ribo-Zero (Illumina) depletion step as to remove ribosomal
RNA from total RNA by the use of biotinylated Ribo-Zero oligos.
Libraries were subjected to sequencing on a NextSeq 500 instrument
(Illumina) to yield 75 bp single-end reads, resulting in 23–28 million
75 bp single end reads per sample. The 3 adapter sequence
(AGATCGGAAGAGCACAC) was trimmed using the fastx_clipper.
Reads were pre-mapped onto small nuclear RNA, tRNA and rRNA.
The remaining unmapped reads were then mapped onto the human
GRCh37 reference genome (Ensembl annotation bundle 75) using
STAR 2.4.0i allowing only unique mapping with a maximum of two
mismatches. Separate BedGraph files were generated for the sense
and antisense strand. Reads were counted across annotated genes
using HTseq set to mode “union,” feature type “exon” and minimum
alignment quality of 10. For the MetAP1 KO cell line, two biological
replicate samples were sequenced and for the WT cell line three. The
unfiltered reads per kilobase of exon per million fragments (RPKM)
values of protein-coding genes displayed a bimodal distribution,
where approximately one third of genes had poor mRNA expression
(i.e. genes with at least one read mapped but with RPKM values
below 1), in line with previous reports, (27). Moreover, typically less
than 2% of these poorly expressed genes have a corresponding
protein expression detected using label-free shotgun proteomics.
Therefore, and besides considering only unique reads from the map-
ping, only protein-coding genes with  1 RPKM in all biological
replicates of both conditions were retained for differential expression
analysis. Differential expression analysis was performed using the
Bioconductor package DESeq2 (Stanford, CA) in the R statistical
programming environment. To determine significantly regulated
genes, an adjusted p value threshold of 0.01 was applied. The fold
change calculations for differentially expressed genes was deter-
mined by DESeq2 and represent the log2 change in expression level
(i.e. counts) for the MetAP1 KO versus the HAP1 control setup.
RNA-seq sequencing data is accessible through GEO Series acces-
sion number GSE103405 in NCBI’s Gene Expression Omnibus (28)
with reviewer password: wpuxikegfnkjjkx.
LC-MS/MS Analysis and Peptide Identification—Peptides were
separated by nano-LC and directly analyzed with a Q Exactive instru-
ment (Thermo Scientific, Bremen, Germany) operating in MS/MS
mode as described before (29). More specifically, all samples were
analyzed via LC-MS/MS on an Ultimate 3000 RSLC nano LC (Thermo
Fisher Scientific) in-line connected to a Q Exactive mass spectrom-
eter (Thermo Fisher Scientific). The sample mixture was first loaded
on a trapping column (made in-house, 100 m i.d.  20 mm, 5 m
beads C18 Reprosil-HD, Dr. Maisch, Ammerbuch-Entringen, Ger-
many). After flushing from the trapping column, the sample was
loaded on an analytical column (made in-house, 75 m i.d.  150
mm, 3 m beads C18 Reprosil-HD, Dr. Maisch). Peptides were
loaded with loading solvent (0.1% TFA in water) and separated with a
linear gradient from 98% solvent A (0.1% formic acid in water) to
55% solvent B (0.1% formic acid in water/acetonitrile, 20:80 (v/v)) in
30 min at a flow rate of 300 nL/min. This was followed by a 5 min wash
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reaching 99% solvent B. The mass spectrometer was operated in
data-dependent, positive ionization mode, automatically switching
between MS and MS/MS acquisition for the 10 most abundant peaks
in each MS spectrum. The source voltage was 3.4 kV, and the
capillary temperature was 275 °C. One MS1 scan (m/z 400–2000,
AGC target 3 106 ions, maximum ion injection time 80 ms) acquired
at a resolution of 70 000 (at 200m/z) was followed by up to 10 tandem
MS scans (resolution 17 500 at 200 m/z) of the most intense ions
fulfilling predefined selection criteria (AGC target, 5  104 ions; max-
imum ion injection time, 60 ms; isolation window, 2 Da; fixed first
mass, 140 m/z; spectrum data type, centroid; underfill ratio, 2%;
intensity threshold, 1.7  104; exclusion of unassigned, 1, 5–8, 8
charged precursors; peptide match preferred; exclude isotopes, on;
dynamic exclusion time, 20 s). The HCD collision energy was set to
25% normalized collision energy, and the polydimethylcyclosiloxane
background ion at 445.120025 Da was used for internal calibration
(lock mass).
Raw data files were searched with MaxQuant (30) using the An-
dromeda search engine (31) (version 1.5.4.1) and MS/MS spectra
searched against the Swiss-Prot database (taxonomy Homo sapiens;
20,195 entries; May 2016 version) for N-terminal proteome analyses,
or a two amino acids N-terminally truncated version of the Swiss-Prot
database was used to avoid contribution of N-terminal peptide abun-
dances to the overall LFQ protein calculations in case of shotgun
proteome analyses. In both cases potential contaminants present in
the contaminants.fasta file that comes with MaxQuant were automat-
ically added.
A precursor mass tolerance was set to 20 ppm for the first search
(used for nonlinear mass recalibration) and set to 4.5 ppm for the main
search. For shotgun proteome analyses, trypsin/P (i.e. cleavages
among lysine/arginine-proline residues were allowed) was selected as
enzyme setting and up to two missed cleavage were allowed. Methi-
onine oxidation was searched as fixed modifications, whereas N-ter-
minal protein acetylation was set as variable modification. In case of
N-terminal proteome enriched samples, ArgC was selected as en-
zyme setting as cleavage after lysine residues is obstructed by acy-
lation of their side chains. Cleavages among arginine-proline residues
were considered and semi-specific free N terminus was chosen as
digestion mode. Methionine oxidation, carbamidomethylation of cys-
teines and heavy acetylation at lysine side-chains (Acetyl:2H(3)C13(2)
(K)) were searched as fixed modifications, whereas acetylation and
heavy (Acetyl:2H(3)C13(2) (N-term)) acetylation on protein N termini
were set as variable modifications. The false discovery rate for pep-
tide and protein identification was set to 1%, and the minimum
peptide length was set to 7. The minimum score threshold for both
modified and unmodified peptides was set to 40. The match between
runs function was enabled and proteins were quantified by the Max-
LFQ algorithm integrated in the MaxQuant software (32) in case of
shotgun proteome analysis. Here, a minimum of two ratio counts and
only unique peptides were considered for protein quantification.
The mass spectrometry proteomics data (i.e. the total list of iden-
tified proteins and modified peptides (next to the evidence file) in case
of shotgun and N-terminal proteomics respectively)) have been de-
posited to the ProteomeXchange Consortium via the PRIDE (33)
partner repository with the data set identifier PXD006638. Annotated,
mass-labeled MS/MS spectra can be viewed on MS-Viewer (http://
msviewer.ucsf.edu/prospector/cgi-bin/msform.cgi?formmsviewer)
(34) using the search keys umhkpodlaj (supplemental Table S2A),
4adxtut9up (supplemental Table S2B) and 7balnvbgbr (for the 33
peptides corresponding to single-peptide based protein identifica-
tions in supplemental Table S3). In case of the supplemental Table
S2B data set, only assigned ion peaks are visualized on MS-Viewer.
Complete annotated spectra can be viewed using the deposited data
and MaxQuant Viewer.
Quantification of the Degree of Protein Nt-acetylation—To quantify
the degree of protein in vivo Nt-acetylation, raw data files were
searched with Mascot using the Mascot Daemon interface (version
2.5.1, Matrix Science) and MS/MS spectra searched against the
Swiss-Prot database (taxonomy Homo sapiens; 20,172 entries; Jan-
uary 2017 version). The Mascot search parameters were set as fol-
lows; methionine oxidation to methionine-sulfoxide, heavy acetylation
at lysine side-chains (Acetyl:2H(3)C13(2) (K)) and carbamidomethyla-
tion of cysteine were set as fixed modifications. To enable identifica-
tion quantification of the degree of Nt-acetylation, acetylation versus
heavy acetylation of N termini (Acetyl:2H(3)C13(2) N-term) was se-
lected as quantification option, and carried out using the Mascot
Distiller Quantitation Tool (version 2.5.1.0). Mass tolerance was set to
10 ppm on the precursor ion (with Mascot’s C13 option set to 1) and
to 20 mmu on fragment ions. Peptide charge was set to 1, 2, 3
and instrument setting was put to ESI-QUAD. Endoproteinase semi-
Arg-C/P (Arg-C specificity with arginine-proline cleavage allowed)
was selected as enzyme allowing for 1 missed cleavage.
In case of N-terminal peptide analyses, only peptides that were
ranked one, have a minimum amino acid length of seven, scored
above the threshold score set at 99% confidence, displayed a start
position of 1 or 2 and belonged to the category of N termini compliant
with the rules of initiator methionine (iMet) processing (10) or repre-
sented actin N termini, were withheld. More specifically, iMet proc-
essing was considered in the case of iMet-starting N termini followed
by any of the following amino acids; Ala, Cys, Gly, Pro, Ser, Thr, Met,
or Val. Data management was done in ms_lims (35). Whenever the
degree of protein in vivo Nt-acetylation could be calculated for Mas-
cot identifications with Mascot Distiller based quantifications, data
was considered for the analysis reported under the section ‘Pro-
teome-wide characterization of Nt-acetylation profiles’ in case of
matching MaxQuant N-terminal peptide identifications.
Software Packages for Statistics and Data Visualization—For basic
data handling, normalization, statistics (if not stated otherwise), and
annotation enrichment analysis, we used the freely available open-
source bioinformatics platform Perseus (version 1.5.3.2) (36). Perseus
was used for nonsupervised hierarchical clustering and the genera-
tion of heat maps, profile and scatter plots. Furthermore, 1D and 2D
annotation enrichment analysis was performed using the Perseus
software (37) with a two-sided test with Benjamini-Hochberg FDR
correction. Data analysis after uploading the protein groups file ob-
tained from MaxQuant database searching was performed as de-
scribed previously (38). All replicate samples were grouped and LFQ-
intensities log(2) transformed. Proteins with less than three valid
values in at least one group were removed and missing values were
imputed from a normal distribution around the detection limit (with 0.3
spread and 1.8 downshift).
Experimental Design and Statistical Rationale of the Proteome and
Transcriptome Analyses—We analyzed the proteomes and matching
N-terminal proteomes of a subset of 12 samples corresponding to 3
biological triplicates per setup i.e.WT, MetAP1 KO, and Bengamide B
treated WT and MetAP1 KO HAP1 cells) using a label-free intensity
based proteomics approach. In addition, we profiled matching tran-
scriptomes of non-inhibitor treated samples corresponding to at least
two biological replicates per condition. More specifically, for the
MetAP1 KO cell line, two biological replicate samples were se-
quenced and for the WT cell line three biological replicate samples.
Lens-free Cell Imaging and Calculation of Cell Doubling—Holo-
graphic lensless imaging of cell cultures grown in parallel was per-
formed using Cytonote devices from Iprasense with a resolution of
1–2 m. By placing the Cytonote devices consisting of a LED for
illumination and a CMOS image sensor in contact with the cell culture
vessels (i.e. 25 cm2 falcons) in an incubator, the interference pattern
with the sample (i.e. the interference between the partially coherent
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incident light and the light scattered by the cells in culture) was
captured. From the holographic pattern, the sample image is recon-
structed by applying the Horus software, including cell segmentation
and basic analysis functions. The extremely wide field of view (30
mm2) results in relevant statistics from single images.
Confluency of cell culture monitored using lens-free imaging over
the course of 24 h before the addition of Bengamide B and the
following 48 h, was fitted with an exponential model using the
Doubling Time Online Calculator (http://www.doubling-time.com/
compute.php). Cell doubling time was calculated from the assigned
growth rate as follows: ln(2)/growth rate and represented in hours.
RESULTS
To elucidate the omics-wide effects of MetAP perturbation
and to study the redundant action and proteome-wide sub-
strate specificity profiles of human MetAP1 and MetAP2 in
general, an attempt was made to create human MetAP1 and
MetAP2 knockout cells in the HAP1 haploid cell line. Using
CRISPR/Cas9 editing, the Cas9 endonuclease is targeted by
a pair of guide RNAs to generate double stranded DNA
breaks, a process followed by non-homologous end-joining
(NHEJ) repair that is accompanied by a precise DNA deletion
of the locus of interest (39). By producing frameshift mutants
of the gene of interest, CRISPR/Cas9 editing can generate
custom human knockout cells. Consequently, genome engi-
neering using CRISPR-mediated gene knockout is especially
straightforward in haploid human cell lines and this way,
frameshift mutants were obtained for MetAP1 and MetAP2 in
HAP1 cells. However, as confirmed by Western blotting anal-
ysis and the mass spectrometric detection of MetAP1 (iden-
tified based on the exclusive detection of 6 unique peptides in
merely all (inhibitor-treated) WT setups) (Fig. 1A), a functional
mutant clone (i.e. a 179 bp insertion in exon 4 (see Experi-
mental Procedures)) was obtained only in case of MetAP1. In
case of MetAP2, the frameshift resulted in the production of
an N-terminally truncated MetAP2 proteoform which still re-
tained (part of) its activity as deduced from the unaltered iMet
retention profiles observed (data not shown). Interestingly,
despite the unaltered MetAP2 expression observed at the
transcript level (supplemental Table S1), a 2- and 4-fold in-
crease of MetAP2 was observed at the proteome level in case
of Bengamide B treated wild type cells or in MetAP1 KO cells
and Bengamide B treated MetAP1 KO cells, respectively
(Fig. 1A).
MetAP1 Knockout Cells Display Altered Proliferation Rates
and Cellular Morphology Next to Increased Sensitivity Toward
MetAP Inhibition—Because MetAP1 and/or MetAP2 inhibition
was previously linked to altered cell proliferation, we first
determined the effects of MetAP1 knockout and chemical
MetAP inhibition—using Bengamide B as a nanomolar inhib-
itor of MetAPs 1 and 2 (24)—on cell proliferation. Using time
lapse data obtained by lensless cell culture imaging of cells in
culture; cell densities, cell sizes and growth rates of WT and
MetAP1 mutant cells were quantitatively evaluated and com-
pared. As deduced from the monitored confluency measure-
ments of cell cultures before and after the addition of Beng-
amide B (Fig. 1B), cell doubling time calculations revealed a
near 2-fold increase in the doubling time of MetAP1 knockout
versus WT cells (i.e. from 17 h to 31 h) when monitoring
confluency during the first 24h after platting. Interestingly,
although the proliferation rates of WT HAP1 remained essen-
tially unaltered during the next 24 h of cultivation, the doubling
rate of MetAP1 knockout cells more closely approached that
of WT cells (i.e. 20 h), indicating a delay in cell proliferation,
especially during the first phase after plating. The difference in
cell doubling becomes even more pronounced on addition of
the MetAP inhibitor Bengamide B. Here a doubling time of
28 h was observed in the case of Bengamide B treated WT
cells, whereas 75 h was required to achieve cell doubling of
Bengamide B treated MetAP1 knockout HAP1 cells (i.e. an
over 4-fold increase in doubling time as compared with its
isogenic WT counterpart). As such, a correlation between the
loss of MetAP1 expression and its inhibitory effect on cell
proliferation can clearly be observed (Fig. 1B), indicating that
the lack of MetAP1 expression in HAP1 cells can not entirely
be compensated for by the increased MetAP2 expression
levels observed (Fig. 1A). Interestingly, although a fibroblast-
like morphology can be observed in case of both HAP1 cell
lines, MetAP1 mutant cells show on average a 30% increase
in attached cell size (i.e. from 17 to 22 m in diameter) (Fig. 2).
Because MetAP1 has previously been implicated in cell cycle
progression through G2/M phase (40), a delayed G2/M phase
progression can likely account for this observation.
Impaired iMet Processing of the Known MetAP1/2 Sub-
strate 14-3-3 in MetAP1 Knockout Cells—Next, we assessed
the functional effect of the introduced frameshift mutation in
MetAP1 by probing the extent of iMet retention of the known
MetAP1/2 substrate, 14-3-3 (24) (i.e. iMet-14-3-3), a protein
previously shown to act as a cellular indicator for the
combined readout of (perturbed) MetAP activity in human
(41).
As a reference sample, Bengamide B treated cells were
sampled in parallel. Here, the inhibitor was used at a final
concentration of 0.1 g per ml for 24h of incubation. Using a
monoclonal antibody raised against an N-terminal peptide
corresponding to the iMet unprocessed N terminus of 14-3-3
(i.e. iMet-14-3-3), changes in MetAP dependent iMet proc-
essing efficiencies of iMet-14-3-3  could be monitored.
When compared with total 14-3-3  protein levels, the basal
levels of iMet-14-3-3 increased about 50% in untreated
MetAP1 KO cells (Fig. 3) whereas on Bengamide B treatment,
a 3.4 fold and 4 fold increase of iMet-14-3-3 was observed
in case of WT cells and MetAP1 KO cells, respectively. As
such, MetAP1 deletion clearly reduces the efficiency of iMet-
14-3-3 processing and the use of higher concentrations or
prolonged incubation with Bengamide B didn’t lead to a fur-
ther increase of iMet-14-3-3 (data not shown). Noteworthy, a
cell dependence in the increase in the ratio of unprocessed
versus total 14-3-3 on Bengamide B treatment has been
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reported previously, further hinting to cell type dependent
MetAP efficiencies.
Proteome-wide Characterization of iMet Retention Pro-
files—N-terminal proteome enriched replicate samples were
analyzed by 1D nano LC-MS/MS using 3h gradients on a
quadrupole Q Exactive Orbitrap instrument (42) and subjected
to label-free, ion intensity-based peptide quantitation and
quantification of the degree of N-terminal acetylation (see
below) using MaxQuant (30) and Mascot respectively. N-ter-
minal peptide enrichment was used to investigate proteome-
wide alterations in iMet retention on genetic MetAP1 deletion
and/or chemical MetAP inhibition among others. More spe-
cifically, 3 biological replicate proteome samples were ob-
tained in case of WT, MetAP1 KO and Bengamide B treated
WT and MetAP1 KO HAP1 cells.
In case of N-terminal proteome enriched samples, all sam-
ples were reduced and S-alkylated and the primary protein
amines blocked using an N-hydroxysuccinimide ester of (sta-
ble isotopic encoded) acetate at the protein level (i.e. an NHS
ester of 13C2D3-acetate) to enable the assignment and the
calculation of the degree of in vivo Nt-acetylation (see below)
(43). N-terminal peptide enrichment by SCX was performed as
FIG. 1. A, MetAP protein expression analysis in MetAP1 KO HAP1 cells and on MetAP inhibition. LFQ values of MetAP1 (orange) and
MetAP2 (blue) are shown for all four setups analyzed. Bars represent the average values of three biological repeats and the error bars represent
standard deviations of these values. Protein quantification values of MetAP1 and MetAP2 were based on the identification of 6 and 13 unique
peptides, respectively. In the inset, Western blotting analyses of corresponding HAP1 WT and MetAP1 KO cell lysates are shown immuno-
blotted with antibodies specific for MetAP1, MetAP2 and -actin. B, Deletion of MetAP1 in HAP1 cells reduces cell proliferation rates in analogy
to chemical MetAP inhibition. Cell proliferation of WT and MetAP1 mutant HAP1 cells monitored by lens-free imaging over a period of 72 h.
Acquisition and phase reconstruction of cultures of human WT and MetAP1 mutant HAP1 cells seeded at 2–5% confluency, incubated at 37 °C
and treated with vehicle or Bengamide B after 24h of cultivation was performed. Cell counts were recorded in a 29.4 mm2 field of view
containing about 20,000 cells on confluency in case of HAP1 WT cells. The results shown are representative for two independent experiments.
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described previously (2). The eluted fractions enriched for
N-terminal peptides were subjected to 1D LC-MS/MS analy-
sis. When using the Andromeda and Mascot peptide search
engines, 1767 iMet compliant (see methods) protein N termini
derived from 1282 human proteins were identified in total
(supplemental Tables S2A and S2B). Of these N termini, 1506
started at position 1 or 2, whereas 261 had a start position
beyond protein position 2. As reported previously, the latter
category of N termini are indicative of alternative translation
initiation events (44, 45). Of the 1631 N termini with intensity-
based peptide MaxQuant quantification data (supplemental
Table S2A), 407 N termini were identified in all setups ana-
lyzed (25% of all identified protein N termini).
When performing a 1D annotation enrichment (37) on the
modified N-terminal peptide intensities obtained using Max-
Quant (supplemental Table S2B), and only considering iMet
compliant categories of N termini (i.e. A, MA, C, MC, MD,
ME, MF, G, MG etc.), significant changes (p 	 0.01) in the
abundance of certain N-terminal categories in the MetAP1
KO could be observed when compared with the WT setup
(Fig. 4).
More specifically, the steady state levels of MS-, MP-, and
MA- N termini are significantly increased in the knockout as
compared with their WT levels, whereas their processed
counterparts (i.e. S- and A- N termini) are significantly re-
duced. MV-, MT-, and MG- termini are only significantly af-
fected on MetAP inhibition in general or by the additional
inhibition of MetAP2 in MetAP1 knockout cells (Fig. 4A).
Peptide intensity profile plots also reflect these significant
changes observed (Fig. 4B).
Proteome-wide Characterization of Nt-acetylation Pro-
files—Because our previous work revealed a kinetic compe-
tition between NATs and MetAPs (20), we also assessed
(potential differences in) protein Nt-acetylation levels.
Overall, as deduced from the very high correlation ob-
served, the degree of Nt-acetylation remained essentially un-
altered when comparing the Nt-acetylomes of the different
setups analyzed (supplemental Fig. S1 and supplemental
Table S2A). This observation hints to the fact that the de-
gree of iMet processing has only minor effects on the
steady-state Nt-acetylation levels of Nt-proteoforms when-
ever detectable (i.e. iMet-processed and iMet unprocessed
Nt-proteoforms).
Interestingly however, 3 MAP-starting N termini displayed
on average a 25% increase in the degree of Nt-acetylation
observed when comparing the MetAP1 KO to the WT setup
(i.e. MTHFD1, EIF2A and ATIC) (supplemental Fig. S1),
whereas several (iMet unprocessed) NatA type substrate N
termini were also substantially affected in their degree of
Nt-acetylation when comparing inhibitor treated MetAP1 KO
versus inhibitor treated WT setups.
FIG. 2. Altered size and morphology of MetAP1 KO HAP1 cells. Acquisition and phase reconstruction of cultures of human WT and
MetAP1 mutant HAP1 cells. Mean cell diameter of WT (A) and MetAP1 (B) mutant cell cultures are indicated in m. The difference in size
between WT and MetAP1 KO HAP1 cells was statistically significant (p 	 0.001, student t test).
FIG. 3. Impaired iMet processing of 14-3-3 in MetAP1 knock-
out HAP1 cells. HAP1 MetAP1 KO or WT cells were treated with
vehicle (DMSO) or Bengamide B for 24 h. Cell lysates were resolved
by SDS-PAGE, transferred to PVDF membrane, and immunoblotted
with antibodies specific for 14-3-3 or iMet 14-3-3 (i.e. the iMet
unprocessed form of 14-3-3). The levels of iMet 14-3-3 were quan-
tified by densitometry and then normalized to 14-3-3.
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Shotgun Proteome Analysis Reveal Changes in Protein Ex-
pression Profiles on Perturbation of MetAP Activity of Proteins
Implicated in Lipid Metabolism, Cytoskeleton Organization,
and Protein Synthesis—Shotgun proteome analysis was per-
formed to monitor quantitative differences in steady-state
protein expression levels by high-resolution mass spectrom-
etry (MS) based proteomics using single LC runs and label-
free protein quantitation (32). Of the 3 biological replicate
samples analyzed per setup (i.e. WT, MetAP1 KO and Beng-
amide B treated WT and MetAP1 KO HAP1 cells) and thus 12
proteome samples analyzed in total, 4971 unique proteins
could be identified at a peptide and protein false discovery
rate (FDR) of 1%. Label-free quantification was performed to
enable relative proteome comparisons (see also methods) by
use of the intensity values (LFQ) obtained using the MaxLFQ
algorithm (30, 32). Of note, N-terminal peptide intensities were
not considered for the LFQ calculations to avoid contribution
of N-terminal peptide abundances to the overall LFQ protein
calculations (see methods). After log2 transformation of the
obtained LFQ values, a multiscatter plot was calculated to-
gether with the Pearson correlation. The very high Pearson
correlations observed (i.e. an average Pearson correlation of
0.98 and all above 0.95) between the different replicates and
samples analyzed overall point to the high reproducibility of
the chromatographic separations and MS detectability among
the different runs (supplemental Fig. S2). Protein expression
profiling using a two-way ANOVA test was performed to re-
veal proteins of which the expression level significantly differs
between the genotype (p 	 0.001) and treatment samples
(p 	 0.01). Log2 transformed LFQ values were grouped for all
replicate samples and only proteins with minimally 3 valid
values in at least one setup were considered, overall permit-
FIG. 4. Proteome-wide characterization of iMet retention profiles. A, Bar chart representation of significantly regulated (FDR 	 1%)
normalized enrichment scores (-1 to 1 max) of N-terminal categories are shown for the KO, KO  Inh. or WT  Inh. versus WT setups. (left:
down in KO, KO  Inh. and/or WT  Inh.; right: up in KO, KO  Inh. and/or WT  Inh.). Term enrichment was determined using the 1D
annotation enrichment algorithm embedded in the Perseus software suite and p values were corrected for multiple hypotheses testing using
the Benjamini and Hochberg false discovery rate. Only corrected p values 	0.01 were considered. B, Individual profile plots of normalized
N-terminal peptide intensities across all four conditions assayed are shown. N-terminal categories for which N termini with significantly altered
abundancies could be observed (except for MK- N termini) were highlighted in red and blue in case of iMet-processed and iMet-retaining N
termini, respectively.
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ting differential protein expression analysis of 3,386 unique
proteins (supplemental Table S3). Missing data values were
replaced with imputed values from the corresponding normal
distribution around the detection limit. Overall, 278 protein
groups were found significantly regulated dependent on the
genotype (p 	 0.001) and 183 protein groups dependent on
Bengamide B treatment (p 	 0.01). The intensities of signifi-
cantly regulated proteins are shown as heat maps after z-
score transformation and non-supervised hierarchical row
clustering (Fig. 5).
Relative enrichment of the indicated gene categories (Uni-
Prot keywords) calculated using the 1D annotation enrich-
ment algorithm (37) point to significant expression changes
(p 	 0.02) in four main protein categories linked to the terms;
“protein synthesis,” “organelle,” “lipids/membrane,” and “cell
connection/cytoskeleton” (Fig. 6). Although all four categories
were affected on MetAP1 deletion (e.g. downregulation of
protein synthesis and lipid metabolism, and upregulation of
cytoskeletal proteins), only proteins implicated in protein syn-
thesis and more specifically ribosome biogenesis were found
to be significantly downregulated on Bengamide B treatment
of control cells.
Western blot analyses were performed to substantiate
some of the genotype and/or inhibitor dependent quantitative
changes observed in the protein expression levels. When
probing for the differentially expressed proteins COTL1,
FIG. 5. Z score heat map representations of cluster analysis reveal proteins with differential abundance dependent on genotype or
treatment. Non-supervised hierarchical clustering of z-scored MS intensities of significant genotype (WT or MetAP1 KO) (A) and treatment
(untreated or Bengamide B treatment) (B) regulated proteins after two-way ANOVA are represented. 278 protein groups were found significantly
regulated dependent on the genotype (p 	 0.001) and 183 protein groups dependent on Bengamide B treatment (p 	 0.01) (supplemental
Table S3). Green indicates low intensities whereas red indicates high intensities.
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KRT18, CRABP2, RL26A, DUSP9, and HMGCS (Fig. 7), both
methods were found to be in excellent agreement.
Protein Expression Changes in the Context of Protein N-ter-
minal Amino Acid Identity and Transcript Levels Using Deep
Transcriptomics—In line with the unaffected steady-state pro-
tein levels of the MetAP1/2 substrate 14-3-3 (Fig. 3 and
supplemental Table S3), when performing annotation enrich-
ment of protein N-terminal identities and using the 1D anno-
tation enrichment algorithm (37) on the normalized protein
intensities and independent of iMet processing (i.e. all 20
possible categories were considered MA, MC, MD, ME, …),
no significant difference in the occurrence of N-terminal pro-
tein identities could be observed when comparing regulated
versus nonregulated proteins.
Further, we systematically compared the transcriptome and
proteome changes on MetAP1 knockout. When only consid-
ering the shotgun proteomes of untreated control and
MetAP1 KO cells, for 97% of the proteins quantified by MS, a
transcript abundance estimate was obtained by means of
RNA sequencing (supplemental Table S1). The Pearson cor-
FIG. 6. Bar Chart representation of normalized annotation enrichment scores. Bar Chart representation of significantly regulated (FDR	
2%) normalized annotation enrichment scores (2.5 to 1 max) of UniProt keyword annotations are shown for the KO, KO  Inh. or WT 
Inh. versus WT setups. (left: down in KO, KO  Inh. and/or WT  Inh.; right: up in KO, KO  Inh. and/or WT  Inh.). Term enrichment was
determined using the 1D annotation enrichment algorithm embedded in Perseus (36, 37) and p values were corrected for multiple hypotheses
testing using the Benjamini and Hochberg false discovery rate. Only corrected p values 	0.02 were considered.
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relation of transcript and protein abundance was found to be
0.6 (Figs. 8A and 8B). The correlation of mRNA abundance
ratios with protein abundance ratios was moderate (Pearson
r  0.28) (Fig. 8C).
By performing a gene ontology term enrichment analysis to
charachterize global effects on the transcript as well as pro-
teome level, a 2D annotation enrichment analysis (37) was
performed based on a nonparametric Mann-Whitney test
(FDR 	 0.02) using the Perseus software (36) (Fig. 9). Al-
though the effect on processes linked to cell proliferation was
mainly reflected in the reduced transcript levels, processes
such as DNA replication and sterol biosynthesis were down-
regulated both at the transcriptome and proteome level in
MetAP1 knockout cells. Consistent with the antiproliferative
effect of MetAP1 inhibition and reflected in the lowered abun-
dancy of a multitude of ribosomal proteins (supplemental
Table S3), downregulation of (mitochondrial) translation pro-
cesses was also found to occur at both omics levels.
Processes upregulated at the transcript and steady-state
proteome level of MetAP1 knockout cells include the positive
regulation of cell adhesion and extracellular structure organi-
zation next to secretory processes such as vesicle organiza-
tion, exocytosis and Golgi vesicle transport. Furthermore, al-
though a(n) (slight) upregulation of proteins implicated in
protein folding (e.g. chaperonnes) and the biosynthesis of
nucleobase-containing compounds could be observed, the
corresponding mRNA levels were downregulated.
DISCUSSION
Although chemical inhibition and knockdown studies on the
topic of MetAPs have been reported previously, the high
efficiency of iMet excision and incompleteness of inhibition or
knockdown next to the redundant actions of MetAPs ob-
served precludes general conclusions of independent MetAP
activities. Although both MetAPs have been listed as “core
essentialome” components in the human haploid HAP1 cell
line and thus likely represent highly essential proteins (46), a
functional MetAP1 mutant HAP1 clone edited by CRISPR/Cas
to contain a frameshift mutation in the fourth coding exon was
nonetheless successfully obtained. The use of isogenic hu-
man haploid cells in a variety of genetic studies, confirms the
validity of the use of the HAP1 haploid cell line (or its parental
line KBM7) as a model system compared with a “standard”
diploid cell line.
With this cell model at hand, we pursued to study the
omics-wide effect of MetAP1 deletion and general MetAP
inhibition. In line with previous reports, a correlation between
MetAP expression levels and cellular MetAP inhibitory effect
could be observed. Further, iMet retention levels were in-
versely correlated with cellular proliferation rates.
FIG. 7. Western blot validation of
genotype and/or inhibitor dependent
quantitative proteome changes ob-
served. A, Western blotting results and
B, LFQ based expression changes ob-
served are shown in case of COTL1,
KRT18, CRABP2, RL26A, DUSP9 and
HMGCS. An unspecific loading control is
indicated as reference.
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Because ectopic MetAP expression and protein expression
levels of MetAPs was reported to be positively correlated with
the increased resistance of cell lines against MetAP inhibition
(47, 48), the specific increase in MetAP2 expression levels
observed on MetAP1 deletion and/or MetAP inhibition, points
to reprogramming of the cell enabling the cell to cope with the
loss of MetAP.
Further, iMet retention profiles determined by positional
proteomics revealed statistically significant changes in the
steady-state abundances of (M)S-, (M)P- and MA- N termini.
More specifically, iMet-retaining and iMet-processed proteo-
forms of these N termini were found to be respectively up-
and downregulated in the MetAP1 KO cells. On additional
inhibition of MetAP2 or MetAP inhibition in general, all NatA
type N termini (M)S-, (M)A- and M(P)-, (M)T-, (M)V- and (M)G-
were affected, meaning that iMet processing of MV-, MT- and
MG- termini were only found significantly affected on (addi-
tional) inhibition of MetAP2. This observation might be ex-
plained by the (partially) overlapping specificity of MetAP1
and MetAP2 (in line with Frottin et al. (10)), which in case of
MetAP1 deletion and for MV-, MT- and MG- termini was
compensated for by (the increased expression of) MetAP2.
More likely however, in line with the previously determined in
vitro substrate specificity profiles of MetAP1 and MetAP2,
MetAP2 may display a much higher or even exclusive action
over these type of N termini (11). More specifically, Xiao et al.
showed that the catalytic activity of human MetAP1 toward
MV- andMT- peptides was up to two orders of magnitude lower
than that of MetAP2 pointing to the fact that MetAP2 is mainly
responsible for processing of MV- and MT- N termini (11).
Nonetheless, MetAP2 is unable to restore levels of iMet
processing observed in case of MS-, MP-, and MA- N termini,
indicating the manifold higher or exclusive activity of MetAP1
over these type of N termini.
Viewing the previously revealed kinetic competition be-
tween NATs and MetAPs (20), to our surprise, only few protein
N termini (e.g. MAP- starting N termini) were identified as
differentially Nt-acetylated when comparing the Nt-acety-
lomes of WT and MetAP1 KO cells. The effect observed is
likely because of Nt-acetylation being unable to keep up with
the increased levels of specific iMet-retaining N termini of
nascent polypeptides, making them more easily observable in
case of sub-optimal NAT substrates, including MAP- N ter-
mini displaying a proline at position 3, a residue known to
Fig. 8. Density-enhanced scatterplots between proteome and
transcriptome expression levels comparing WT and MetAP1
knockout HAP1 cells. Per gene and only in case of two valid repli-
cate values for the proteome and transcriptome setups analyzed,
mean RPKM values were compared with their corresponding mean
iBAQ (intensity based absolute quantification) values (51). Pearson
correlations values of 0.584 (A) and 0.549 (B) were observed in case
of WT and KO proteome samples, respectively. C, When comparing
mRNA with protein abundance ratios, the Pearson correlation was 0.28.
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diminish Nt-acetylation and lower iMet cleavage susceptibility
(11, 49). However, because in most cases, only the steady-
state levels of the main proteoforms can be detected, no
general conclusions regarding the influence of iMet excision
on Nt-acetylation can be drawn easily.
Interestingly, differential iMet excision did not appear to
account for the differential protein expression patterns ob-
served. On the other hand, and despite the rather moderate
correlation of mRNA abundance ratios with protein abun-
dance ratios, proteome-changes were typically reflected by
altered transcript abundances.
Finally, on perturbation of MetAP activity, and besides the
differential expression of proteins implicated in cell prolifera-
tion, omics expression profiling revealed differential expres-
sion of cytoskeletal proteins, proteins associated with protein
and lipid and cholesterol biosynthesis. In this context, it is
noteworthy that MetAP2 inhibitors, originally developed as an-
ticancer therapies, have proven anti-obesity effects by their
inhibitory action over the sterol regulatory element binding pro-
tein (SREBP), thereby resulting in reduced lipid and cholesterol
biosynthesis (50). Based on our results, MetAP1 can also be put
forward as a potential target for the discovery and development
of new anti-obesity besides anticancer therapeutic strategies.
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DATA AVAILABILITY
The mass spectrometry proteomics data have been depos-
ited to the ProteomeXchange Consortium with the data set
identifier PXD006638. Annotated, mass-labeled MS/MS spec-
tra can be viewed on MS-Viewer (http:// msviewer.ucsf.edu/
prospector/cgi-bin/msform.cgi?form_msviewer) (34) using
the search keys umhkpodlaj (supplemental Table S2A),
4adxtut9up (supplemental Table S2B) and 7balnvbgbr (for the
FIG. 9. 2D annotation enrichment of proteome and transcriptome expression changes. The 2D-annotation enrichment scores for GO
biological processes (GOBP names) were plotted for the proteome and transcriptome expression changes observed when comparing the
MetAP1 KO versus WT setups. The fold change of log2 transformed means of corresponding normalized iBAQ and RPKM values were
considered only in case of two valid replicate values for the proteome and transcriptome setups analyzed. The biological processes
represented by green dots show common upregulation at both mRNA and protein levels, whereas orange dots indicate simultaneous
downregulation or, in case of the points with low absolute Y-values, represent biological processes downregulated at the mRNA level only. The
process represented by black dots exhibit downregulations at the mRNA level, while being upregulated (GOBP protein folding) or non-
regulated at the level of the proteome. Only corrected p values 	0.02 were considered.
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33 peptides corresponding to single-peptide based protein
identifications in supplemental Table S3). RNA-seq sequenc-
ing data is accessible through GEO Series accession number
GSE103405 in NCBI’s Gene Expression Omnibus with re-
viewer password: wpuxikegfnkjjkx (see also detailed descrip-
tion in Experimental Procedures).
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